Phillip Low

Credentials: · · ·

History

Dr. Tosio Narahashi Laboratory of Cellular Pharmacology and Toxicology Department of Pharmacology Northwestern University
Postdoctoral Research Fellow Dr. P.J. Dyck Department of Neurology Mayo Clinic in Rochester
Neurology Royal Prince Alfred Hospital
1976–1979
Resident St. Vincent's Hospital
1967–1968
UNIV OF SYDNEY, SYDNEY, NEW SOUTH WALES
1963–1967

Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.8M · Mayo Clinic Rochester
2015–2020
Autonomic Rare Diseases Clinical Research Consortium - Datamining Supplement
National Institute of Neurological Disorders and Stroke · U54
Project lead · $2.1M · Vanderbilt University Medical Center
2009–2020
Phase 1 Study of Autologous Mesenchymal Stem Cell in Multiple System Atrophy
Food and Drug Administration · R01
Contact PI · $600K · Mayo Clinic Rochester
2014–2018
Pathogenesis and Diagnosis of Multiple System Atrophy (P01)
National Institute of Neurological Disorders and Stroke · P01
Contact PI · $6.6M · Mayo Clinic Rochester
2003–2018

Mesenchymal Stem Cell Therapy in Multiple System Atrophy
Principal investigator · Active not recruiting · Phase 1, Phase 2
Mayo Clinic
2012–2027
Study of Rifampicin in Multiple System Atrophy
Principal investigator · Terminated · Phase 3
Phillip Low
2011–2013
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Principal investigator · Completed · Phase 3
Chelsea Therapeutics
2008–2009